Your provider at PlexusDx can personalize your dose escalation to balance weight loss goals with symptom comfort
Retatrutide A triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously
Brain GLP-1 and insulin sensitivity
Virtual Wellness Voyage May 16, 2024 2 min read Updated: Sep 9, 2025 We all have heard the hype around these magic weight management medications and their outstanding weight loss results
This metabolic heterogeneity suggests that cancer cells can adapt their metabolism based on the availability of substrates and the tumor microenvironment
Results from the SURPASS program's phase 3 trials indicate that tirzepatide, administered weekly in doses of 5mg, 10mg, and 15mg, significantly enhances glycemic control in T2D